西班牙裔人口中的癌症流行病学:需求和机会
Naoko Ishibe1, Joanne W Elena2, Lisa Gallicchio2
1Scientific Consulting Group, Inc., Gaithersburg, Maryland.
概括
在西班牙裔/拉丁裔人口中推进癌症流行病学研究需要解决数据收集挑战. 未来的研究必须捕捉出生地和原籍国,使用文化相关的工具和社区参与.
科学领域:
- 癌症流行病学 癌症流行病学
- 人口健康 人口健康
- 健康差异 在健康上的差异
背景情况:
- 西班牙裔/拉丁裔 (H/L) 人群中的癌症负担异质,因出生地和原产国而异.
- 现有的数据收集方法经常汇总H/L种群,掩盖显著的差异.
- 种族/种族数据收集的系统性挑战阻碍了癌症负担的准确评估.
研究的目的:
- 总结H/L人群癌症流行病学的证据差距.
- 讨论在这个人口群体中推进癌症研究的下一步.
- 为更具包容性和准确的HL癌症研究提供战略信息.
主要方法:
- 审查发现的证据缺口.
- 基于NCI研讨会"西班牙裔人口中的癌症流行病学"的讨论.
- 分析数据收集和报告中的系统性挑战.
主要成果:
- 在H/L人群中,癌症负担存在显著差异.
- 文化相关的工具,增加H/L参与者代表性,以及适当的方法是至关重要的.
- 融资机制和利用现有资源可以解决确定优先事项.
结论:
- 未来对H/L人群的癌症流行病学研究必须收集有关出生和原产国的详细数据.
- 采用文化特定的评估工具和协作,社区参与的方法至关重要.
- 需要加强研究,以有意义地解决日益增长的H / L人口中的癌症负担.
更多相关视频
07:49Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
Published on: April 18, 2025
114
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
222
相关概念视频
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Psychoneuroimmunology: Diabetes and Cancer
24
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
24
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Mouse Models of Cancer Study
5.5K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.5K
